Radiodynamic therapy with CsI(na)@MgO nanoparticles and 5-aminolevulinic acid
Abstract Background Radiodynamic therapy (RDT) holds the potential to overcome the shallow tissue penetration issue associated with conventional photodynamic therapy (PDT). To this end, complex and sometimes toxic scintillator–photosensitizer nanoconjugates are often used, posing barriers for large-...
Main Authors: | Fangchao Jiang, Chaebin Lee, Weizhong Zhang, Wen Jiang, Zhengwei Cao, Harrison Byron Chong, Wei Yang, Shuyue Zhan, Jianwen Li, Yong Teng, Zibo Li, Jin Xie |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2022-07-01
|
Series: | Journal of Nanobiotechnology |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12951-022-01537-z |
Similar Items
-
In Vivo Study of the Efficacy and Safety of 5-Aminolevulinic Radiodynamic Therapy for Glioblastoma Fractionated Radiotherapy
by: Junko Takahashi, et al.
Published: (2021-09-01) -
Gold Nanoparticles and Their Alternatives for Radiation Therapy Enhancement
by: Daniel R. Cooper, et al.
Published: (2014-10-01) -
An Orthotopic Model of Glioblastoma Is Resistant to Radiodynamic Therapy with 5-AminoLevulinic Acid
by: Charles Dupin, et al.
Published: (2022-08-01) -
Nanocomposites for X-Ray Photodynamic Therapy
by: Zaira Gadzhimagomedova, et al.
Published: (2020-06-01) -
Growth of thallium-doped CsI/CsCl/KCl eutectics and their scintillation properties
by: Yui Takizawa, et al.
Published: (2022-08-01)